Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Indians, North American | 27 | 2024 | 511 | 6.110 |
Why?
|
| Neoplasms | 7 | 2024 | 748 | 2.150 |
Why?
|
| Vaping | 5 | 2020 | 122 | 1.960 |
Why?
|
| Electronic Nicotine Delivery Systems | 4 | 2020 | 193 | 1.220 |
Why?
|
| Qualitative Research | 2 | 2024 | 169 | 1.090 |
Why?
|
| Inuits | 4 | 2014 | 9 | 1.010 |
Why?
|
| Smoking | 6 | 2019 | 465 | 0.970 |
Why?
|
| Smoking Cessation | 6 | 2020 | 386 | 0.870 |
Why?
|
| Middle Aged | 26 | 2024 | 6796 | 0.840 |
Why?
|
| United States | 18 | 2023 | 2030 | 0.770 |
Why?
|
| Health Services, Indigenous | 3 | 2014 | 10 | 0.760 |
Why?
|
| Adult | 15 | 2024 | 7359 | 0.690 |
Why?
|
| Prevalence | 10 | 2019 | 472 | 0.680 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2019 | 279 | 0.680 |
Why?
|
| Aged | 19 | 2024 | 5157 | 0.660 |
Why?
|
| Tobacco Smoking | 1 | 2019 | 38 | 0.650 |
Why?
|
| Cardiovascular Diseases | 8 | 2021 | 346 | 0.640 |
Why?
|
| Body Weight | 1 | 2019 | 246 | 0.640 |
Why?
|
| Male | 26 | 2024 | 12842 | 0.630 |
Why?
|
| Tobacco Use Disorder | 2 | 2020 | 115 | 0.620 |
Why?
|
| Humans | 36 | 2024 | 26777 | 0.610 |
Why?
|
| Cigarette Smoking | 1 | 2019 | 76 | 0.600 |
Why?
|
| Physicians, Primary Care | 1 | 2018 | 9 | 0.600 |
Why?
|
| Female | 26 | 2024 | 14421 | 0.600 |
Why?
|
| Patient Preference | 1 | 2018 | 28 | 0.590 |
Why?
|
| Patient Education as Topic | 1 | 2018 | 87 | 0.570 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 111 | 0.550 |
Why?
|
| Cotinine | 3 | 2020 | 45 | 0.490 |
Why?
|
| Public Health Practice | 1 | 2014 | 13 | 0.470 |
Why?
|
| United States Indian Health Service | 1 | 2014 | 14 | 0.470 |
Why?
|
| Health Policy | 1 | 2014 | 59 | 0.440 |
Why?
|
| Early Detection of Cancer | 3 | 2023 | 121 | 0.400 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2007 | 322 | 0.400 |
Why?
|
| Health Status | 3 | 2019 | 145 | 0.390 |
Why?
|
| Primary Health Care | 3 | 2018 | 145 | 0.380 |
Why?
|
| Risk Factors | 14 | 2021 | 2009 | 0.370 |
Why?
|
| Colorectal Neoplasms | 2 | 2023 | 132 | 0.370 |
Why?
|
| Young Adult | 5 | 2020 | 2576 | 0.340 |
Why?
|
| Urban Population | 3 | 2014 | 69 | 0.330 |
Why?
|
| Health Services Accessibility | 2 | 2023 | 89 | 0.310 |
Why?
|
| Data Collection | 2 | 2022 | 101 | 0.300 |
Why?
|
| Pilot Projects | 3 | 2024 | 385 | 0.300 |
Why?
|
| Cohort Studies | 6 | 2021 | 857 | 0.290 |
Why?
|
| Hypercholesterolemia | 1 | 2007 | 17 | 0.280 |
Why?
|
| Alaska | 5 | 2014 | 37 | 0.280 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 909 | 0.280 |
Why?
|
| Mass Screening | 2 | 2024 | 141 | 0.270 |
Why?
|
| Adolescent | 6 | 2020 | 2952 | 0.260 |
Why?
|
| American Native Continental Ancestry Group | 1 | 2006 | 22 | 0.260 |
Why?
|
| Health Services Research | 1 | 2006 | 40 | 0.260 |
Why?
|
| Travel | 1 | 2005 | 12 | 0.250 |
Why?
|
| Outpatients | 1 | 2005 | 42 | 0.250 |
Why?
|
| Selection Bias | 1 | 2005 | 13 | 0.250 |
Why?
|
| Age Factors | 4 | 2020 | 714 | 0.240 |
Why?
|
| Hypertension | 2 | 2007 | 304 | 0.230 |
Why?
|
| Urban Health Services | 1 | 2004 | 8 | 0.230 |
Why?
|
| Medical Audit | 1 | 2004 | 15 | 0.230 |
Why?
|
| Poverty | 1 | 2024 | 81 | 0.230 |
Why?
|
| Interviews as Topic | 1 | 2024 | 150 | 0.230 |
Why?
|
| Health Facilities | 1 | 2023 | 11 | 0.220 |
Why?
|
| Quality of Health Care | 1 | 2003 | 77 | 0.210 |
Why?
|
| Saliva | 2 | 2019 | 94 | 0.200 |
Why?
|
| Diabetes Mellitus | 4 | 2019 | 207 | 0.190 |
Why?
|
| Oklahoma | 3 | 2021 | 970 | 0.190 |
Why?
|
| Lymphatic System | 1 | 2021 | 11 | 0.190 |
Why?
|
| Hematologic Neoplasms | 1 | 2021 | 18 | 0.180 |
Why?
|
| Smokers | 2 | 2020 | 124 | 0.180 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 78 | 0.180 |
Why?
|
| Longitudinal Studies | 6 | 2021 | 400 | 0.180 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 65 | 0.180 |
Why?
|
| Coronary Disease | 2 | 2017 | 118 | 0.180 |
Why?
|
| Flavoring Agents | 1 | 2019 | 15 | 0.170 |
Why?
|
| Tobacco Use Cessation | 1 | 2020 | 25 | 0.170 |
Why?
|
| Telomere Homeostasis | 1 | 2019 | 10 | 0.170 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 340 | 0.160 |
Why?
|
| Aging | 1 | 2007 | 943 | 0.160 |
Why?
|
| Tobacco, Smokeless | 1 | 2020 | 43 | 0.160 |
Why?
|
| Obstetric Labor Complications | 1 | 1999 | 18 | 0.160 |
Why?
|
| Labor, Induced | 1 | 1999 | 19 | 0.160 |
Why?
|
| Pregnancy Outcome | 1 | 1999 | 128 | 0.150 |
Why?
|
| Information Dissemination | 1 | 2018 | 35 | 0.150 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 441 | 0.150 |
Why?
|
| Smoking Prevention | 1 | 2018 | 87 | 0.140 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2017 | 28 | 0.140 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2018 | 60 | 0.140 |
Why?
|
| Forecasting | 1 | 2017 | 71 | 0.140 |
Why?
|
| Tobacco Products | 1 | 2020 | 190 | 0.130 |
Why?
|
| Biomarkers | 2 | 2018 | 731 | 0.130 |
Why?
|
| Communication | 1 | 2018 | 166 | 0.130 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 915 | 0.130 |
Why?
|
| Electrocardiography | 1 | 2017 | 391 | 0.130 |
Why?
|
| Incidence | 5 | 2021 | 546 | 0.120 |
Why?
|
| Risk Assessment | 1 | 2017 | 586 | 0.120 |
Why?
|
| Cultural Characteristics | 1 | 2014 | 27 | 0.120 |
Why?
|
| History, 19th Century | 1 | 2014 | 36 | 0.120 |
Why?
|
| History, 21st Century | 1 | 2014 | 49 | 0.120 |
Why?
|
| Universities | 1 | 2014 | 115 | 0.110 |
Why?
|
| History, 20th Century | 1 | 2014 | 83 | 0.110 |
Why?
|
| Anxiety | 1 | 2014 | 133 | 0.110 |
Why?
|
| Quality Indicators, Health Care | 2 | 2004 | 49 | 0.110 |
Why?
|
| Social Support | 1 | 2014 | 122 | 0.110 |
Why?
|
| Depression | 1 | 2014 | 209 | 0.100 |
Why?
|
| Students | 1 | 2014 | 188 | 0.100 |
Why?
|
| Stress, Psychological | 1 | 2014 | 207 | 0.100 |
Why?
|
| Washington | 2 | 2004 | 12 | 0.100 |
Why?
|
| Arizona | 3 | 2007 | 38 | 0.100 |
Why?
|
| Obesity | 2 | 2015 | 648 | 0.090 |
Why?
|
| Retrospective Studies | 3 | 2021 | 2426 | 0.090 |
Why?
|
| Midwestern United States | 2 | 2007 | 38 | 0.080 |
Why?
|
| Mood Disorders | 1 | 2007 | 24 | 0.070 |
Why?
|
| Regression Analysis | 2 | 2005 | 209 | 0.070 |
Why?
|
| Mortality | 1 | 2007 | 43 | 0.070 |
Why?
|
| Anxiety Disorders | 1 | 2007 | 58 | 0.070 |
Why?
|
| Brain Injuries | 1 | 2007 | 49 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 980 | 0.070 |
Why?
|
| Insulin Resistance | 2 | 2015 | 165 | 0.070 |
Why?
|
| Sex Factors | 3 | 2019 | 444 | 0.070 |
Why?
|
| Comorbidity | 2 | 2005 | 252 | 0.070 |
Why?
|
| Health Status Indicators | 1 | 2005 | 25 | 0.060 |
Why?
|
| Socioeconomic Factors | 3 | 2020 | 241 | 0.060 |
Why?
|
| Cholesterol | 1 | 2007 | 182 | 0.060 |
Why?
|
| Death Certificates | 1 | 2005 | 1 | 0.060 |
Why?
|
| Cause of Death | 1 | 2005 | 65 | 0.060 |
Why?
|
| Surgical Procedures, Operative | 1 | 2005 | 46 | 0.060 |
Why?
|
| Health Surveys | 3 | 2014 | 77 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2021 | 1216 | 0.060 |
Why?
|
| Veterans | 1 | 2005 | 66 | 0.060 |
Why?
|
| Urban Health | 1 | 2004 | 12 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2004 | 231 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 473 | 0.050 |
Why?
|
| Health Behavior | 1 | 2004 | 153 | 0.050 |
Why?
|
| Proportional Hazards Models | 2 | 2019 | 213 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2005 | 701 | 0.050 |
Why?
|
| CpG Islands | 1 | 2021 | 23 | 0.050 |
Why?
|
| Protein Interaction Maps | 1 | 2021 | 11 | 0.050 |
Why?
|
| Epigenomics | 1 | 2021 | 29 | 0.050 |
Why?
|
| Academic Medical Centers | 1 | 2021 | 73 | 0.050 |
Why?
|
| Medicare | 1 | 2021 | 118 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2005 | 605 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2000 | 65 | 0.040 |
Why?
|
| Hospitalization | 1 | 2021 | 188 | 0.040 |
Why?
|
| Computational Biology | 1 | 2021 | 150 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2021 | 149 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2015 | 384 | 0.040 |
Why?
|
| Hospital Charges | 1 | 1999 | 7 | 0.040 |
Why?
|
| Risk | 1 | 2019 | 133 | 0.040 |
Why?
|
| Confidence Intervals | 1 | 1999 | 66 | 0.040 |
Why?
|
| Medical Records | 1 | 1999 | 49 | 0.040 |
Why?
|
| Life Style | 1 | 2019 | 83 | 0.040 |
Why?
|
| Umbilical Cord | 1 | 1999 | 34 | 0.040 |
Why?
|
| Self Concept | 1 | 2018 | 52 | 0.040 |
Why?
|
| Length of Stay | 1 | 1999 | 215 | 0.040 |
Why?
|
| Survival Rate | 1 | 2017 | 407 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 1999 | 841 | 0.030 |
Why?
|
| Ohio | 1 | 2014 | 7 | 0.030 |
Why?
|
| Pregnancy | 1 | 1999 | 1127 | 0.030 |
Why?
|
| Perception | 1 | 2014 | 82 | 0.030 |
Why?
|
| Glucose Intolerance | 2 | 2005 | 22 | 0.030 |
Why?
|
| Educational Status | 1 | 2007 | 110 | 0.020 |
Why?
|
| Cross-Cultural Comparison | 1 | 2005 | 21 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2005 | 46 | 0.020 |
Why?
|
| Hawaii | 1 | 2005 | 12 | 0.020 |
Why?
|
| Japan | 1 | 2005 | 22 | 0.020 |
Why?
|
| Asian Americans | 1 | 2005 | 40 | 0.020 |
Why?
|
| Mexican Americans | 1 | 2005 | 13 | 0.020 |
Why?
|
| Arteriosclerosis | 1 | 2005 | 29 | 0.020 |
Why?
|
| Psychometrics | 1 | 2005 | 117 | 0.020 |
Why?
|
| Minority Groups | 1 | 2005 | 61 | 0.020 |
Why?
|
| Heart | 1 | 2005 | 219 | 0.010 |
Why?
|
| Age Distribution | 1 | 2004 | 70 | 0.010 |
Why?
|
| Logistic Models | 1 | 2004 | 399 | 0.010 |
Why?
|
| African Americans | 1 | 2005 | 350 | 0.010 |
Why?
|
| North Dakota | 1 | 2002 | 15 | 0.010 |
Why?
|
| Diabetic Nephropathies | 1 | 2002 | 19 | 0.010 |
Why?
|
| Albuminuria | 1 | 2002 | 23 | 0.010 |
Why?
|
| Glycated Hemoglobin A | 1 | 2002 | 64 | 0.010 |
Why?
|
| Triglycerides | 1 | 2002 | 117 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2002 | 162 | 0.010 |
Why?
|
| Lipids | 1 | 2002 | 195 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2002 | 351 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 1924 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2002 | 300 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2002 | 162 | 0.010 |
Why?
|
| Insulin | 1 | 2002 | 310 | 0.010 |
Why?
|
| Hyperlipidemias | 1 | 2000 | 36 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2000 | 298 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2005 | 2261 | 0.010 |
Why?
|
| Child | 1 | 2005 | 2141 | 0.010 |
Why?
|